wb 4101 has been researched along with Glial Cell Tumors in 2 studies
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haga, T | 1 |
| Haga, K | 1 |
| Atlas, D | 1 |
| Adler, M | 1 |
2 other studies available for wb 4101 and Glial Cell Tumors
| Article | Year |
|---|---|
Characterization by [3H]dihydroergocryptine binding of alpha-adrenergic receptors in neuroblastoma X glioma hybrid cells.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Cell Line; Dihydroergotoxine; Dioxanes; Glioma; Guanos | 1981 |
alpha-adrenergic antagonists as possible calcium channel inhibitors.
Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Brain; Calcium; Cell Line; Cell Membran | 1981 |